Freenome

FreenomeFreenome
Freenome

Freenome

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Website
2014Active402
Rate
Advertise here

About

Freenome is a biotechnology company dedicated to outpacing cancer through early detection. Their intelligent screening platform utilizes multiomics technology and artificial intelligence, combined with a standard blood draw, to identify cancer in its earliest, most treatable stages. This approach aims to make a significant difference by enabling earlier intervention and improving patient outcomes.

Technology stack

detected 2026-07-02
EmailGoogle Workspace
Stack
jQueryWordPress
Analytics
Google Tag Manager
SEO
Yoast SEO
Support
HubSpot
Cookie consent
OneTrust
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Freenome do?

Freenome is a biotechnology company dedicated to outpacing cancer through early detection. Their intelligent screening platform utilizes multiomics technology and artificial intelligence, combined with a standard blood draw, to identify cancer in its earliest, most treatable stages. This approach aims to make a significant difference by enabling earlier intervention and improving patient outcomes.

How much funding has Freenome raised?

Freenome has raised a total of $570M in funding. The most recent round on record is Series D.

Where is Freenome headquartered?

Freenome is headquartered in South San Francisco, California, USA.

When was Freenome founded?

Freenome was founded in 2014.

What industry does Freenome operate in?

Freenome operates in Biotechnology, Healthcare, Artificial Intelligence, Biotech, MedTech, HealthTech.

How many employees does Freenome have?

Freenome has approximately 402 people on record.

What is Freenome's revenue?

StartupHub estimates Freenome's annual revenue at $51.7M (range $27.8M to $157.5M, 71% confidence), based on comparable companies in the sector.

What is Freenome's valuation?

StartupHub estimates Freenome's effective valuation at $560.6M (range $392.4M to $728.7M, 28% confidence), based on comparable companies in the sector.